These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28258424)

  • 1. Patients with negative multi-gene panel testing: a back to the future paradox?
    Sorscher SM
    Fam Cancer; 2017 Jul; 16(3):459. PubMed ID: 28258424
    [No Abstract]   [Full Text] [Related]  

  • 2. Researchers Find Discrepancies in Gene Panel Tests for Cancer.
    Schmidt C
    J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 30053095
    [No Abstract]   [Full Text] [Related]  

  • 3. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
    Frey MK; Kim SH; Bassett RY; Martineau J; Dalton E; Chern JY; Blank SV
    Gynecol Oncol; 2015 Nov; 139(2):211-5. PubMed ID: 26296696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cancer genetics.
    Dean SJ; Farmer M
    Curr Opin Pediatr; 2017 Dec; 29(6):629-633. PubMed ID: 28984800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial.
    Baxter G
    Clin Radiol; 2017 Jan; 72(1):1-2. PubMed ID: 27836105
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
    Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
    JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories.
    Rosenthal ET; Bernhisel R; Brown K; Kidd J; Manley S
    Cancer Genet; 2017 Dec; 218-219():58-68. PubMed ID: 29153097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?
    Domchek SM; Bradbury A; Garber JE; Offit K; Robson ME
    J Clin Oncol; 2013 Apr; 31(10):1267-70. PubMed ID: 23460708
    [No Abstract]   [Full Text] [Related]  

  • 9. Genomic Profiling: Building a Continuum From Knowledge to Care.
    Chen HX; Abrams JS
    JAMA Oncol; 2015 Jul; 1(4):474-5. PubMed ID: 26181257
    [No Abstract]   [Full Text] [Related]  

  • 10. A Life Potentially Saved Through Hereditary Cancer Panel Testing.
    Marks D; McHenry A; Biagi T; Stark E; Borum M; Lin P; Kaltman R
    J Oncol Pract; 2017 Apr; 13(4):279-281. PubMed ID: 28195815
    [No Abstract]   [Full Text] [Related]  

  • 11. Telomerase in bladder cancer: back to a better future?
    Theodorescu D; Cech TR
    Eur Urol; 2014 Feb; 65(2):370-1. PubMed ID: 24184027
    [No Abstract]   [Full Text] [Related]  

  • 12. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality.
    MacConaill LE; Lindeman NI; Rollins BJ
    JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion technology and cancer predispositions.
    Papadopoulos N
    Methods Mol Biol; 2003; 223():415-23. PubMed ID: 12777743
    [No Abstract]   [Full Text] [Related]  

  • 14. Multigene Panel Testing Detects Equal Rates of Pathogenic BRCA1/2 Mutations and has a Higher Diagnostic Yield Compared to Limited BRCA1/2 Analysis Alone in Patients at Risk for Hereditary Breast Cancer.
    Kapoor NS; Curcio LD; Blakemore CA; Bremner AK; McFarland RE; West JG; Banks KC
    Ann Surg Oncol; 2015 Oct; 22(10):3282-8. PubMed ID: 26219241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolving clinical testing landscape of genomic aberrations in solid tumors and hematological malignancies - Insights from evidence-based reviews for B-ALL and breast, brain, and renal cell neoplasia.
    Miron PM; Fang M
    Cancer Genet; 2020 Jun; 244():60-61. PubMed ID: 32473557
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene Panel Testing in Oncology Practice: How Should We Respond?
    Kurian AW; Ford JM
    JAMA Oncol; 2015 Jun; 1(3):277-8. PubMed ID: 26181167
    [No Abstract]   [Full Text] [Related]  

  • 18. UK Groups Pilot Pediatric Gene Testing.
    Cancer Discov; 2016 Jul; 6(7):685-6. PubMed ID: 27170063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients.
    Mandelker D
    Clin Cancer Res; 2016 Aug; 22(16):3987-8. PubMed ID: 27307597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Your Genes: Getting the Best Fit.
    Tempero M
    J Natl Compr Canc Netw; 2017 Sep; 15(9):1083. PubMed ID: 28874592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.